Resistin levels in perivascular adipose tissue and mid-term mortality in patients undergoing coronary artery bypass grafting
Language English Country Czech Republic Media print-electronic
Document type Journal Article
PubMed
34062078
PubMed Central
PMC8820548
DOI
10.33549/physiolres.934661
PII: 934661
Knihovny.cz E-resources
- MeSH
- Biomarkers metabolism MeSH
- Time Factors MeSH
- Enzyme-Linked Immunosorbent Assay MeSH
- Risk Assessment MeSH
- Coronary Artery Bypass * adverse effects mortality MeSH
- Middle Aged MeSH
- Humans MeSH
- Coronary Artery Disease diagnostic imaging metabolism mortality surgery MeSH
- Predictive Value of Tests MeSH
- Prospective Studies MeSH
- Resistin metabolism MeSH
- Risk Factors MeSH
- Aged MeSH
- Adipose Tissue metabolism MeSH
- Treatment Outcome MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Biomarkers MeSH
- Resistin MeSH
- RETN protein, human MeSH Browser
Higher serum resistin levels were reported to be associated with increased mortality risk. We aimed to assess the predictive value of resistin levels in perivascular adipose tissue (PVAT) around the left main coronary artery (LMCA) for mid-term survival of patients with advanced coronary artery disease (CAD).This was a prospective study including patients referred for elective coronary artery grafting in 2016 and 2017, performed using a standard approach. A sample of PVAT was harvested and resistin levels were measured using an enzyme-linked immunosorbent assay. Patients were followed from the day of the procedure until March 2021. In each patient, the SYNTAX score and EuroSCORE II were calculated. The study included 108 patients aged 68.1 ±7.9 years, including 83 men (76.9%). The duration of follow-up was 731 (range, 275-1020) for nonsurvivors and 1418 median (range, 1174-1559) for survivors (p <0.001). Patients who died had a higher SYNTAX score, higher EuroSCORE II, and lower resistin levels in PVAT than survivors (p <0.001, p = 0.004, and p = 0.041, respectively). A stepwise regression analysis revealed that survival was related to resistin concentrations above the median value (hazard ratio [HR], 4.67; 95% CI, 1.02-21.4; p = 0.048) and EuroSCORE II (used as continuous variable; HR, 1.55; 95% CI, 1.16-2.07; p = 0.003). The mid-term mortality in patients with advanced CAD is associated with low resistin concentrations in PVAT surrounding the LMCA.
See more in PubMed
AL-NIMER MS, ALHUSSEINY AH, IBRAHIM AK. Assessment of serum adiponectin and leptin levels in patients with ischaemic heart disease: an association with the ejection fraction, coronary calcium score and coronary. Folia Cardiologica. 2018;13:204–209. doi: 10.5603/FC.2018.0041. DOI
ANTONIADES C, KOTANIDIS CP, BERMAN DS. State-of-the-art review article. Atherosclerosis affecting fat: what can we learn by imaging perivascular adipose tissue? J Cardiovasc Comput Tomogr. 2019;13:288–296. doi: 10.1016/j.jcct.2019.03.006. PubMed DOI PMC
ANTONOPOULOS AS, MARGARITIS M, COUTINHO P, DIGBY J, PATEL R, PSARROS C, NTUSI N, KARAMITSOS TD, LEE R, DE SILVA R, PETROU M, SAYEED R, DEMOSTHENOUS M, BAKOGIANNIS C, WORDSWORTH PB, TOUSOULIS D, NEUBAUER S, CHANNON KM, ANTONIADES C. Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of patients with ischemic heart disease. Arterioscler Thromb Vasc Biol. 2014;34:2151–2159. doi: 10.1161/ATVBAHA.114.303828. PubMed DOI
ANTONOPOULOS AS, SANNA F, SABHARWAL N, THOMAS S, OIKONOMOU EK, HERDMAN L, MARGARITIS M, SHIRODARIA C, KAMPOLI AM, AKOUMIANAKIS I, PETROU M, SAYEED R, KRASOPOULOS G, PSARROS C, CICCONE P, et al. Detecting human coronary inflammation by imaging perivascular fat. Sci Transl Med. 2017;9 doi: 10.1126/scitranslmed.aal2658. PubMed DOI
BOS D, SHAHZAD R, VAN WALSUM T, VAN VLIET LJ, FRANCO OH, HOFMAN A, NIESSEN WJ, VERNOOIJ MW, VAN DER LUGT A. Epicardial fat volume is related to atherosclerotic calcification in multiple vessel beds. Eur Heart J Cardiovasc Imaging. 2015;16:1264–1269. doi: 10.1093/ehjci/jev086. PubMed DOI
CARBONE S, CANADA JM, BILLINGSLEY HE, SIDDIQUI MS, ELAGIZI A, LAVIE CJ. Obesity paradox in cardiovascular disease: where do we stand? Vasc Health Risk Manag. 2019;15:89–100. doi: 10.1016/j.pcad.2019.08.004. PubMed DOI PMC
DEY D, NAKAZATO R, LI D, BERMAN DS. Epicardial and thoracic fat: noninvasive measurement and clinical implications. Cardiovasc Diagn Ther. 2012;2:85–93. PubMed PMC
ELAGIZI A, KACHUR S, LAVIE CJ, CARBONE S, PANDEY A, ORTEGA FB, MILANI RV. An overview and update on obesity and the obesity paradox in cardiovascular diseases. Prog Cardiovasc Dis. 2018;61:142–150. doi: 10.1016/j.pcad.2018.07.003. PubMed DOI
FONTANA A, SPADARO S, COPETTI M, SPOTO B, SALVEMINI L, PIZZINI P, PIZZINI P, FRITTITTA L, MALLAMACI F, PELLEGRINI F, TRISCHITTA V, MENZAGHI C. Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysis. PLoS One. 2015;10:e0120419. doi: 10.1371/journal.pone.0120419. PubMed DOI PMC
FRANSSENS BT, NATHOE HM, VISSEREN FL, VAN DER GRAAF Y, LEINER T SMART Study Group. Relation of epicardial adipose tissue radiodensity to coronary artery calcium on cardiac computed tomography in patients at high risk for cardiovascular disease. Am J Cardiol. 2017;119:1359–1365. doi: 10.1016/j.amjcard.2017.01.031. PubMed DOI
HORWICH TB, FONAROW GC, CLARK AL. obesity and obesity paradox in heart failure. Prog Cardiovasc Dis. 2018;61:151–156. doi: 10.1016/j.pcad.2018.05.005. PubMed DOI
ITO T, SUZUKI Y, EHARA M, MATSUO H, TERAMOTO T, TERASHIMA M, et al. Impact of epicardial fat volume on coronary artery disease in symptomatic patients with a zero calcium score. Int J Cardiol. 2013;167:2852–2858. doi: 10.1016/j.ijcard.2012.07.026. PubMed DOI
KRECKI R, DROZDZ J, SZCZEŚNIAK P, ORSZULAK-MICHALAK D, KRZEMIŃSKA-PAKUŁA M. Novel atherogenesis markers for identification of patients with a multivessel coronary artery disease. Kardiol Pol. 2008;66:1173–1180. PubMed
LAFRAMBOISE WA, DHIR R, KELLY LA, PETROSKO P, KRILL-BURGER JM, SCIULLI CM, LYONS-WEILER MA, CHANDRAN UR, LOMAKIN A, MASTERSON RV, MARROQUIN OC, MULUKUTLA SR, MCNAMARA DM. Serum protein profiles predict coronary artery disease in symptomatic patients referred for coronary angiography. BMC Med. 2012;10:157–160. doi: 10.1186/1741-7015-10-157. PubMed DOI PMC
LUBOS E, MESSOW CM, SCHNABEL R, RUPPRECHT HJ, ESPINOLA-KLEIN C, BICKEL C, PEETZ D, POST F, LACKNER KJ, TIRET L, MÜNZEL T, BLANKENBERG S. Resistin, acute coronary syndrome and prognosis results from the AtheroGene study. Atherosclerosis. 2007;193:121–128. doi: 10.1016/j.atherosclerosis.2006.05.039. PubMed DOI
MANCIO J, OIKONOMOU EK, ANTONIADES C. Perivascular adipose tissue and coronary atherosclerosis. Heart. 2018;104:1654–1662. doi: 10.1136/heartjnl-2017-312324. PubMed DOI
NASHEF SA, ROQUES F, SHARPLES LD, NILSSON J, SMITH C, GOLDSTONE AR, LOCKOWANDT U. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41:734–744. doi: 10.1093/ejcts/ezs043. PubMed DOI
NOSALSKI R, GUZIK TJ. Perivascular adipose tissue inflammation in vascular disease. Br J Pharmacol. 2017;174:3496–3513. doi: 10.1111/bph.13705. PubMed DOI PMC
OIKONOMOU EK, MARWAN M, DESAI MY, MANCIO J, ALASHI A, HUTT CENTENO E, THOMAS S, HERDMAN L, KOTANIDIS CP, THOMAS KE, GRIFFIN BP, FLAMM SD, ANTONOPOULOS AS, SHIRODARIA C, SABHARWAL N, DEANFIELD J, NEUBAUER S, HOPEWELL JC, CHANNON KM, ACHENBACH S, ANTONIADES C. Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data. Lancet. 2018;392:929–939. doi: 10.1016/S0140-6736(18)31114-0. PubMed DOI PMC
PILZ S, WEIHRAUCH G, SEELHORST U, WELLNITZ B, WINKELMANN BR, BOEHM BO, MÄRZ W. Implications of resistin plasma levels in subjects undergoing coronary angiography. Clin Endocrinol (Oxf) 2007;66:380–386. doi: 10.1111/j.1365-2265.2007.02743.x. PubMed DOI
SARACEVIC A, 1, MEDVED I, HRABRIC VLAHS, KOZMAR A, BILIC-ZULLE L, SIMUNDIC AM. The association of systemic inflammatory markers with indicators of stress and cardiac necrosis in patients undergoing aortic valve replacement and revascularization surgeries. Physiol Res. 2020;69:261–274. doi: 10.33549/physiolres.934243. PubMed DOI PMC
SPILIOPOULOS K, BAGIATIS V, DEUTSCH O, KEMKES BM, ANTONOPOULOS N, KARANGELIS D, HASCHEMI A. Performance of EuroSCORE II compared to EuroSCORE I in predicting operative and mid-term mortality of patients from a single center after combined coronary artery bypass grafting and aortic valve replacement. Gen Thorac Cardiovasc Sur. 2014;62:103–111. doi: 10.1007/s11748-013-0311-8. PubMed DOI
SULLIVAN PG, WALLACH JD, IOANNIDIS JP. Meta-analysis comparing established risk prediction models (EuroSCORE II, STS Score, and ACEF Score) for perioperative mortality during cardiac surgery. Am J Cardiol. 2016;118:1574–1582. doi: 10.1016/j.amjcard.2016.08.024. PubMed DOI
VERSTEYLEN MO, TAKX RA, JOOSEN IA, NELEMANS PJ, DAS M, CRIJNS HJ, HOFSTRA L, LEINER T. Epicardial adipose tissue volume as a predictor for coronary artery disease in diabetic, impaired fasting glucose, and non-diabetic patients presenting with chest pain. Eur Heart J Cardiovasc Imaging. 2012;13:517–523. doi: 10.1093/ehjci/jes024. PubMed DOI
WANG H, CHEN DY, CAO J, HE ZY, ZHU BP, LONG M. High serum resistin level may be an indicator of the severity of coronary disease in acute coronary syndrome. Chin Med Sci J. 2009;24:161–166. doi: 10.1016/S1001-9294(09)60082-1. PubMed DOI